REPORT ON THE RISK ASSESSMENT OF GHB IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS
Enregistré dans:
EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION, REPORT ON THE RISK ASSESSMENT OF GHB IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS. LISBOA, EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION, 2002, 92 p.
Ref.
112931
Localisation:
SIIS D17.161
Palabras clave:
Drogas de síntesis, Drogas ilegales, Drogodependencias, Efectos, Evaluación, Éxtasis, Fármacos, Riesgo, Toxicidad
Drogas de síntesis, Drogas ilegales, Drogodependencias, Efectos, Evaluación, Éxtasis, Fármacos, Riesgo, Toxicidad
Documents similaires: REPORT ON THE RISK ASSESSMENT OF GHB IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS
- REPORT ON THE RISK ASSESSMENT OF PMMA IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS
- REPORT ON THE RISK ASSESSMENT OF TMA-2 IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS
- REPORT ON THE RISK ASSESSMENT OF MBDB IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS. GUIDELINES FOR THE RISK ASSESSMENT OF NEW SYNTHETIC DRUGS
- CARACTERISTICAS FARMACOLOGICAS DE LAS DROGAS RECREATIVAS (MDMA Y OTRAS ANFETAMINAS, KETAMINA, GHB, LSD Y OTROS ALUCINOGENOS)
- REPORT ON THE RISK ASSESSMENT OF 2C-I, 2C-T-2 AND 2C-T-7 IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS
- REPORT ON THE RISK ASSESSMENT OF BZP IN THE FRAMEWORK OF THE COUNCIL DECISION ON NEW PSYCHOACTIVE SUBSTANCES